Cite

HARVARD Citation

    Celsa, C. et al. (n.d.). Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?. Digestive and liver disease. pp. S33-. [Online]. 
  
Back to record